-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
January 01, 2014 - These nonspecific factors are particularly important to
control when the evaluation of outcome relies … Although meditation
programs may have an impact on healthy populations,
we limited our evaluation of … This was
mostly driven by two important evaluation criteria: risk
of bias and inconsistencies in the
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - zonisamide16;
and an inter-study comparison of
bioequivalence studies submitted
to the Dutch Medicines
Evaluation … While data on BCS class for the innovator versus
generic antiepileptic medication evaluation was
presented … Search Methodology
Search Strategy Innovator versus Generic Antiepileptic Drug Evaluation
(original … Maliepaard,
201118
Inter-study
comparison of
bioequivalence
studies submitted to
the Dutch Medicines
Evaluation … New Evidence:
While data on BCS class for the innovator versus generic
antiepileptic medication evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - zonisamide16;
and an inter-study comparison of
bioequivalence studies submitted
to the Dutch Medicines
Evaluation … While data on BCS class for the innovator versus
generic antiepileptic medication evaluation was
presented … Search Methodology
Search Strategy Innovator versus Generic Antiepileptic Drug Evaluation
(original … Maliepaard,
201118
Inter-study
comparison of
bioequivalence
studies submitted to
the Dutch Medicines
Evaluation … New Evidence:
While data on BCS class for the innovator versus generic
antiepileptic medication evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
March 01, 2011 - The length of the evaluation period will be considered when evaluating the benefits and risks (short-term … meta-analyses, we will conduct formal tests for publication
bias by using Begg’s and Egger’s tests, including evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
November 27, 2012 - Thus, the diagnostic
evaluation of patients found to be positive for antibody to the hepatitis C virus … KDIGO clinical practice
guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis … KDOQI US Commentary
on the KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation … KDOQI US Commentary on the KDIGO Clinical Practice Guideline for the
Prevention, Diagnosis, Evaluation … Timely HCV
testing is necessary and prompt medical evaluation and appropriate treatment are needed to
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_research-protocol.pdf
April 03, 2014 - cycles and often presents with sleepiness.8
Other sleep disorders should also be considered during evaluation … methodological limitations have prevented conclusive evidence
synthesis for these treatments.17-26
The evaluation … FSS)12, 28; Glasgow Sleep Impact Index (GSII)32;
Insomnia Severity Index (ISI)12, 28 ; Leeds Sleep evaluation … Clinical guideline for the evaluation
and management of chronic insomnia in
adults. … [The guidelines
for the evaluation and management of
insomnias in Japanese primary care].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_protocol-140716.pdf
April 03, 2014 - cycles and often presents with sleepiness.8
Other sleep disorders should also be considered during evaluation … methodological limitations have prevented conclusive evidence
synthesis for these treatments.17-26
The evaluation … FSS)12, 28; Glasgow Sleep Impact Index (GSII)32;
Insomnia Severity Index (ISI)12, 28 ; Leeds Sleep evaluation … Clinical guideline for the evaluation
and management of chronic insomnia in
adults. … [The guidelines
acupressure for insomnia: a systematic for the evaluation and management of
review
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
September 18, 2012 - commercialization are complex processes, and the regulatory review process is
overseen by the Center for Biologics Evaluation … Once a vaccine is ready
for clinical evaluation, an Investigational New Drug application must be submitted … The clinical evaluation of a vaccine typically consists of three phases.8 Phase I studies—which
typically … and the Clinical Immunization Safety Assessment
Network.13
Despite the stringent regulation and evaluation … Food and Drug Administration regulation and evaluation of
vaccines.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
September 29, 2010 - Title: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-
Citrullinated Peptide Testing for the Evaluation … about risks for future disability in their children,
prompting visits to their pediatricians for evaluation … effectivehealthcare.ahrq.gov/
repFiles/2007_10DraftMethodsGuide.pdf), and the AHRQ Guidance for the Evaluation … Literature Selection: Detailed Evaluation
Each “include” and “unsure” article will then be examined … KQ.4 and KQ.5
using the AHRQ system for grading the strength of evidence (AHRQ Guidance for the
Evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Response
TEP #2 Results –
KQ2
My main concerns (specifically with Q2a) are the use
of SMDs for the evaluation … Section Comment Response
Public Reviewer
Susan Bergman
General I am sorry to see that there was no evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Response
TEP #2 Results –
KQ2
My main concerns (specifically with Q2a) are the use
of SMDs for the evaluation … Section Comment Response
Public Reviewer
Susan Bergman
General I am sorry to see that there was no evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
May 01, 2011 - Healthcare Research and Quality
GRADE approach (Grading of Recommendations,
Assessment, Development, and Evaluation … The evaluation of pain should include longterm
followup of outcomes beyond the acute hospital setting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/child-obesity-future_research.pdf
March 31, 2010 - Few of the studies we reviewed reported process
evaluation, which would provide useful insight regarding … These included the need for
better evaluation of community-based studies, attention to barriers and … They
particularly support the need for improved methods for the evaluation of community based
interventions … Few of the studies we reviewed reported process
evaluation, which would provide useful insight regarding … They
particularly support the need for improved methods for the evaluation of community based
interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - Layout 1
Background
Juvenile idiopathic arthritis (JIA) is the
most common rheumatologic disease in
childhood, with an overall prevalence of 7
to 400 per 100,000 children. JIA is an
important cause of chronic disease in
childhood, with prevalence similar to type I
diabetes mellitus. Several classification
systems ha…
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
June 01, 2012 - Reviewers must understand where in the evaluation process a test is being used. … Technologic advances for evaluation of cervical cytology: is newer better? … Evaluation of Cervical Cytology. … Technologic advances for evaluation of cervical cytology: is newer better? … Evaluation of Cervical Cytology.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
June 01, 2012 - Reviewers must understand where in the evaluation process a test is being used. … Technologic advances for evaluation of cervical cytology: is newer better? … Evaluation of Cervical Cytology. … Technologic advances for evaluation of cervical cytology: is newer better? … Evaluation of Cervical Cytology.
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - An annual cross-sectional evaluation of DMARD use
determined that at least 85% of the observed patterns … would be expected to be
higher than for those patients initiating these therapies, we
restricted our evaluation … However, our
evaluation was restricted to patients who had compatible
diagnoses and had started DMARD … Methods for evaluation of
medication adherence and persistence using automated databases. … Termination of slow acting antirheu-
matic therapy in rheumatoid arthritis: a 14-year prospective evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
May 23, 2005 - Study Quality and Strength of Evidence Evaluation
Study Quality and Strength of Evidence Evaluation … Study Quality and Strength of Evidence Evaluation (continued)
apply to these small evidence bases … Study Quality and Strength of Evidence Evaluation (continued)
B-4
Decision Point 5
Data Homogeneous … Study Quality and Strength of Evidence Evaluation (continued)
Moderate Quality Pathway
Decision … Study Quality and Strength of Evidence Evaluation (continued)
Low Quality Pathway
Decision Point
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
November 24, 2014 - This is correct, the evaluation of early optimized therapy was
not the intent of this systematic review
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0718-140819.pdf
March 11, 2013 - Thus, removing these contaminants is an essential
aspect of reducing HAIs, and evaluation of evidence